New glasses could slow Kids' worsening eyesight

NCT ID NCT06816446

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether specially designed spectacle lenses can slow the progression of myopia (nearsightedness) in children aged 6 to 12. Over two years, 185 children will wear either the special lenses or standard single-vision lenses. The goal is to see if the special lenses reduce the need for stronger prescriptions and lower the risk of serious eye problems later in life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

myopia control spectacle lenses

What this could lead to

If successful, these lenses could offer a simple, non-invasive way to slow worsening nearsightedness in children, reducing future eye health risks.

What could go wrong

This is a single trial with 185 participants. The control group switches lenses after one year, which may complicate results. The lenses may not slow myopia significantly or could affect visual comfort.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NUH

    RECRUITING

    Singapore, Singapore

    Contact Phone: •••-•••-•••• Email: •••••@•••••